U.S. Electrical Stock News

ICON stock performance snapshot after recent moves ICON (ICLR) has caught investor attention after a recent share price move, with the stock closing at $125. Short term returns show mixed momentum, including a 0.7% gain over the past day. Over the past week and month, ICON has recorded returns of 5.6% and 16.6% respectively. Performance over the past 3 months and year to date reflects double digit declines, highlighting uneven sentiment around the stock. See our latest analysis for ICON. That...

Why F5’s latest quarter is back in focus F5 (FFIV) is back on investors’ radar after reporting quarterly results that showed higher revenue and profit, raising full year revenue growth guidance and pointing to firm demand in hybrid multicloud and application security. See our latest analysis for F5. That upbeat earnings release sits alongside strong recent share price momentum, with a 1-day share price return of 1.17% and a 90-day share price return of 24.75%. The 3-year total shareholder...

In early May 2026, Innoviva, Inc. reported first-quarter 2026 results, with revenue of US$97.99 million and net income of US$186.6 million, marking a clear turnaround from the prior year’s loss. Around the same time, Innoviva filed a US$207.99 million shelf registration for up to 9,000,000 common shares tied to its employee stock ownership plan, underscoring management’s focus on employee alignment alongside growth in its recurring royalty and Specialty Therapeutics businesses. We’ll now...

In the first quarter of 2026, PDF Solutions, Inc. reported revenue of US$60.13 million, up from US$47.78 million a year earlier, swinging from a net loss of US$3.03 million to net income of US$4.79 million, and reaffirmed guidance for 20% annual revenue growth for 2026. Management highlighted strong momentum in its Exensio and Cimetrix software platforms, growing interest in AI-enabled analytics, and continued build-out of its eProbe inspection systems as it works toward higher long-term...

What Genworth’s latest quarter tells you about the stock Genworth Financial (GNW) put fresh numbers on the table with its first quarter 2026 report, pairing flat revenue and lower net income with stronger operating cash flow and active share repurchases. See our latest analysis for Genworth Financial. Genworth’s share price has held close to US$9.14 despite a 5.9% 1 month share price return and a 30.2% 1 year total shareholder return, which suggests that recent earnings softness and active...

Why IDEX (IEX) is back on investors’ radar IDEX (IEX) has drawn fresh attention after reporting first quarter 2026 results with higher sales and net income, declaring its 126th consecutive quarterly dividend and updating investors on completed share repurchases. See our latest analysis for IDEX. The earnings beat, long dividend record and fresh buyback activity come after a strong run, with a 30 day share price return of 12.01% and a 1 year total shareholder return of 18.18%, suggesting...

Piper Sandler Companies (PIPR) has put capital returns in focus after reporting first quarter 2026 results, pairing higher revenue with a 14% lift in its quarterly dividend and ongoing share repurchases. See our latest analysis for Piper Sandler Companies. Despite the recent earnings release, the stock has seen a 7.73% 7 day share price decline and an 8.04% year to date share price decline. However, the 1 year total shareholder return of 28.89% and very large 3 and 5 year total shareholder...

Setting the scene for Asana stock Asana (ASAN) has been on investors’ radar after recent trading, with the stock closing at $7.05. With mixed short and longer term returns, many are reassessing how its work management platform fits their portfolio. See our latest analysis for Asana. Recent trading has pushed Asana’s 7 day share price return to 11.55% and 30 day return to 13.71%. However, the year to date share price return of 45.60% and 1 year total shareholder return of 59.13% indicate that...

Why Catalyst Pharmaceuticals Stock Is On Investors’ Radar Catalyst Pharmaceuticals (CPRX) has drawn attention after a period of strong share-price moves, with returns over the past month, past 3 months and year all in positive territory according to recent performance data. For investors tracking US biopharmaceutical stocks focused on rare diseases, this kind of sustained positive return profile can prompt a closer look at how the current share price relates to earnings, profitability and...

SoFi Technologies (SOFI) has drawn fresh attention after reporting Q1 2026 earnings that included US$1.1b in net revenue, net income of US$166.7 million, and record loan and deposit balances. See our latest analysis for SoFi Technologies. Despite strong Q1 results, SoFi’s recent 1-day and 90-day share price returns of 1.84% and 23.3% declines contrast with a 1-year total shareholder return of 20.66% and a 3-year total shareholder return above 3x. This points to fading near term momentum but...

Why Danaher Stock Is On Investors’ Radar Now Danaher (DHR) has drawn fresh attention after recent share price moves, with the stock showing a return of about 0.4% over the past day but weaker performance across the month and past 3 months. See our latest analysis for Danaher. At a share price of $175.66, Danaher's recent 30 day share price return of an 8.0% decline and year to date share price return of a 23.8% decline suggest momentum has been fading, despite a smaller 9.2% decline in the 1...

Why Hawkins (HWKN) Is On Investors’ Radar Recent trading in Hawkins (HWKN) has drawn attention after the stock’s recent month and past 3 months performance, prompting investors to reassess what the current price of $167.01 implies. With returns of 13.88% over the past month and 24.28% in the past 3 months, Hawkins’ recent move sits against a backdrop of longer term total returns and a business spanning water treatment, industrial chemicals, and health and nutrition ingredients. See our latest...

Aurinia Pharmaceuticals (AUPH) has drawn fresh attention after reporting first quarter 2026 results. Revenue was US$77.71 million and net income was US$34.36 million, both higher than the prior year period. See our latest analysis for Aurinia Pharmaceuticals. The earnings beat and reiterated 2026 guidance arrived alongside a 4.9% 90 day share price return and an 86.7% 1 year total shareholder return, suggesting strong recent momentum despite short term share price weakness. If Aurinia’s...

Earnings and dividend announcement set the tone for Crown Holdings stock Crown Holdings (CCK) recently reported first quarter 2026 results alongside an affirmation of its regular quarterly dividend, giving investors fresh information on both the company’s operating performance and its ongoing cash return policy. See our latest analysis for Crown Holdings. The recent earnings release, which showed quarterly sales of US$3,259 million and net income of US$175 million, together with the affirmed...

Zscaler (ZS) has drawn fresh attention after user interest picked up around sector moves following Fortinet’s earnings, the company’s upcoming Q3 results on May 26, and new Zero Trust integrations including the IXT secure IoT platform. See our latest analysis for Zscaler. Recent sector swings and Zscaler specific news have created sharp short term moves, with a 1 day share price return of 10.06% and 7 day share price return of 16.92%. Longer term performance is more mixed, including a year to...

In May 2026, Burford Capital reported a very large non-cash revenue loss of US$1.72 billion and a net loss of US$1.63 billion for the first quarter, primarily linked to a capital provision tied to the reversal of its YPF judgment, while also strengthening liquidity through new long-dated debt. At the same time, Burford reshaped its leadership bench by appointing Travis Lenkner as Chief Operating Officer and promoting Carrie Tendler to lead Asset Recovery, signaling a focus on execution,...

Cimpress plc has reported past third-quarter 2026 results showing sales of US$886.21 million versus US$789.47 million a year earlier, with net income of US$13.84 million compared with a net loss of US$8.24 million and basic earnings per share from continuing operations improving from US$0.33 loss to US$0.57. Over the first nine months to March 31, 2026, Cimpress lifted sales to US$2.79 billion and more than doubled net income to US$70.82 million, highlighting materially stronger...

Walker & Dunlop, Inc. has reported past first-quarter 2026 results, with revenue rising to US$301.33 million and net income to US$15.87 million, alongside affirming a quarterly dividend of US$0.68 per share payable on June 4, 2026. Beneath these headline figures, the company highlighted very large growth in transaction volumes and agency lending, supported by complex refinancing deals and higher productivity per banker that helped increase its share of the GSE lending market. We’ll now...

Cipher Digital Inc. recently reported first-quarter 2026 results, with sales falling to US$34.84 million from US$48.96 million a year earlier and net loss widening to US$114.32 million. The company’s deeper loss of US$0.28 per share, alongside comments about ongoing expansion and strong gross margins, has sharpened investor focus on its path to operating efficiency. We’ll now examine how Cipher Digital’s weaker first-quarter revenue and wider loss reshapes the earlier investment narrative...

What recent returns say about MakeMyTrip stock MakeMyTrip (MMYT) has moved sharply in recent months, with a 2.1% gain over the past day, about 7% over the past week, and roughly 32% over the past month. See our latest analysis for MakeMyTrip. While the recent 32% 1 month share price return points to strong short term momentum, this comes after a 38.3% year to date share price decline and a 48% 1 year total shareholder return loss, set against much stronger 3 and 5 year total shareholder...

Armstrong World Industries (AWI) has put investors on alert after its first quarter 2026 update, combining higher year-on-year sales, slightly lower net income and a reaffirmed full year net sales outlook. See our latest analysis for Armstrong World Industries. The reaffirmed 2026 net sales outlook and management's focus on M&A have come after a 16.7% decline in the 90 day share price return, even as the 3 year total shareholder return sits at 157.8%. This suggests long term momentum has been...

Jacobs Solutions (NYSE:J) has been selected as part of a joint venture to design five new underground stations for Sydney Metro West. The contract covers integrated engineering design services for Australia’s largest transportation project. The win expands Jacobs Solutions’ global transportation infrastructure footprint, with a focus on high-performance, sustainable mass transit. For investors watching the infrastructure and engineering space, this new Sydney Metro West mandate puts Jacobs...

Pebblebrook Hotel Trust stock moves draw investor focus Pebblebrook Hotel Trust (PEB) is back on many investors’ radars after a recent stretch of positive share price performance, with the stock up over the past month and past 3 months. See our latest analysis for Pebblebrook Hotel Trust. That recent upswing fits into a broader recovery story, with a 30 day share price return of 13.88% and a 1 year total shareholder return of 53.71% pointing to improving momentum despite a weak 5 year total...

Why Chemours stock is on investors’ radar Chemours (CC) has drawn fresh attention after its first quarter 2026 earnings, where several business segments outperformed expectations, and management highlighted debt reduction, refinancing activity, and reaffirmed full year sales and EBITDA guidance. See our latest analysis for Chemours. That interest has come against a sharp pullback in recent days, with a 1 day share price return of 5.32% decline and a 7 day share price return of 16.85% decline,...